Skip to main content

Overview of Pulmonary Embolism

  • Conference paper
Pulmonary Embolism
  • 132 Accesses

Summary

For too long, Eastern and Western cultures have approached the epidemiology, diagnosis, therapy, and prevention of pulmonary embolism in cultural isolation. Although the discovery of the factor V Leiden genetic mutation has revolutionized the epidemiology of venous thromboembolism in Caucasian populations of European ancestry, this finding has not advanced the epidemiological approach to pulmonary embolism in Japan, because this genetic mutation is so rare in Asians. However, advances in reliable noninvasive diagnostic techniques have been welcomed in the East and the West, particularly the D-dimer ELISA, echocardiography, spiral chest CT scanning, and magnetic resonance imaging. The use of subcutaneously administered low molecular weight heparins has made home treatment possible for pulmonary embolism patients at low risk. Perhaps the most exciting advance in therapy is implementation of routine risk stratification, especially by establishing the status of the right ventricle. Right ventricular hypokinesis on echocardiography is becoming increasingly recognized as a poor prognostic sign. By understanding that pulmonary embolism encompasses a wide clinical spectrum, those patients at high risk of an adverse outcome can be selected for thrombolysis or catheter-based or surgical embolectomy in addition to anticoagulation. Finally, prevention of venous thromboembolism is crucially important. While effective pharmacologic strategies can be implemented, especially with low molecular weight heparins, mechanical measures such as insertion of an inferior vena caval filter are also effective.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as a basis for venous thrombosis. New Engl J Med 330: 517 - 522

    Article  PubMed  CAS  Google Scholar 

  2. Bertina RM, Koeleman BPC, Koster T et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64 - 67

    Article  PubMed  CAS  Google Scholar 

  3. Ridker PM, Hennekens CH, Lindpaintner K (1995) Mutation in the gene coding for coagulation factor V and risks of future myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332: 912 - 917

    Article  PubMed  CAS  Google Scholar 

  4. Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997) Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277: 1305-1307

    Google Scholar 

  5. Bounameaux H, de Moerloose P, Perrier A, Miron MJ (1997) D-dimer testing in suspected venous thromboembolism: an update. Q J Med 90: 437 - 442

    Article  CAS  Google Scholar 

  6. Jardin F, Dubourg O, Bourdarias JP (1997) Echocardiographic pattern of acute cor pulmonale. Chest 111: 209 - 217

    Article  PubMed  CAS  Google Scholar 

  7. Remy-Jardin M, Remy J, Deschildre F et al. (1996) Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 200: 699 - 706

    PubMed  CAS  Google Scholar 

  8. Goodman LR, Lipchik RJ (1996) Diagnosis of acute pulmonary embolism: time for a new approach. Radiology 199: 25 - 27

    PubMed  CAS  Google Scholar 

  9. Lensing AWA, Prandoni P, Brandjes D et al. (1989) Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 320: 342 - 345

    Article  PubMed  CAS  Google Scholar 

  10. Weitz JI (1997) Low-molecular-weight heparins. N Engl J Med 337: 688 - 698

    Article  PubMed  CAS  Google Scholar 

  11. Koopman MMW, Prandoni P, Piovella F et al. (1996) Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared Overview of Pulmonary Embolism 15 with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 334: 682 - 687

    Article  PubMed  CAS  Google Scholar 

  12. Levine M, Gent M, Hirsh J et al. (1996) A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334: 677 - 681

    Article  PubMed  CAS  Google Scholar 

  13. The Columbus Investigators (1997) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337: 657 - 662

    Article  Google Scholar 

  14. Simonneau G, Sors H, Charbonnier B et al. (1997) A comparison of low-molecularweight-heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 337: 663 - 669

    Article  PubMed  CAS  Google Scholar 

  15. Cannon CP, Goldhaber SZ (1995) The importance of rapidly treating patients with acute myocardial infarction. Chest 107: 598 - 600

    Article  PubMed  CAS  Google Scholar 

  16. Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry Lancet. (in press)

    Google Scholar 

  17. Price DT, Ridker PM (1997) Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 127: 895 - 903

    PubMed  CAS  Google Scholar 

  18. Simioni P, Prandoni P, Lensing AWA et al. (1997) The risk of recurrent venous thromboembolism in patients with an Arg500 ---> Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 336: 399 - 403

    Article  PubMed  CAS  Google Scholar 

  19. Ridker PM, Miletich JP, Stampfer MJ et al. (1995) Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation 92: 2800 - 2802

    Article  PubMed  CAS  Google Scholar 

  20. Hirsch DR, Ingenito EP, Goldhaber SZ (1995) Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 274: 335 - 337

    Article  PubMed  CAS  Google Scholar 

  21. Goldhaber SZ (1998) Venous thromboembolism in the Intensive Care Unit: the last frontier for prophylaxis. Chest 113: 5 - 7

    Article  PubMed  CAS  Google Scholar 

  22. Elliott CG (1992) Pulmonary physiology during pulmonary embolism. Chest 101: 1635 - 171S

    Google Scholar 

  23. Anderson FA Jr, Wheeler HB, Goldberg RJ et al. (1991) A population-based perspective of the hospital incidence and case-fatality rates of venous thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med 151: 933938

    Google Scholar 

  24. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L (1997) Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as predictor of mortality. Am Heart J 134: 479 - 487

    Article  PubMed  CAS  Google Scholar 

  25. Kasper W, Konstantinides S, Geibel A et al. (1997) Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 77: 346 - 349

    PubMed  CAS  Google Scholar 

  26. Kasper W, Konstantinides S, Geibel A et al. (1997) Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 30: 1165 - 1171

    Article  PubMed  CAS  Google Scholar 

  27. Goldhaber SZ, Grodstein F, Stampfer MJ et al. (1997) A prospective study of risk factors for pulmonary embolism in women. JAMA 277: 642 - 645

    Article  PubMed  CAS  Google Scholar 

  28. Koonin LM, Atrash HK, Lawson HW, Smith JC (1991) Maternal Mortality Surveillance, United States, 1979-1986. CDC Surveillance Summaries. MMWR 40: 1-8

    Google Scholar 

  29. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 346: 1575 - 1582

    Google Scholar 

  30. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 346: 15821588

    Google Scholar 

  31. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C (1995) Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 346: 1589 - 1593

    Article  PubMed  CAS  Google Scholar 

  32. Daly E, Vessey MP, Hawkins MM (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348: 977 - 980

    Article  PubMed  CAS  Google Scholar 

  33. Jick H. Derby LE, Myers MW, Vasilakis C, Newton KM (1996) Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 348: 981 - 983

    Article  PubMed  Google Scholar 

  34. Grodstein F, Stampfer MJ, Goldhaber SZ (1996) Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 348: 983 - 987

    Article  PubMed  CAS  Google Scholar 

  35. Bergqvist D, Lindblad B (1985) A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 72: 105 - 108

    Article  PubMed  CAS  Google Scholar 

  36. Huber O, Bounameaux H, Borst F, Rohner A (1992) Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 127: 310-313

    Google Scholar 

  37. Prandoni P, Lensing AWA, Büller HR et al. (1992) Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327: 1128 - 1133

    Article  PubMed  CAS  Google Scholar 

  38. Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ (1996) Cancer and venous thromboembolism. Am Heart J 132: 850 - 855

    Article  PubMed  CAS  Google Scholar 

  39. Ridker PM, Glynn RJ, Miletich JP et al. (1997) Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 126: 528 - 531

    PubMed  CAS  Google Scholar 

  40. Simioni P, Prandoni P, Burlina A et al. (1996) Hyperhomocysteinemia and deep-vein thrombosis. A case control study. Thromb Haemost 76: 883-886

    Google Scholar 

  41. den Heijer M, Koster T, Blom HJ (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334: 759 - 762

    Article  Google Scholar 

  42. Ridker PM, Hennekens CH, Selhub J et al. (1997) Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 95: 1777 - 1782

    Article  PubMed  CAS  Google Scholar 

  43. Hughes GRV (1993) The antiphospholipid syndrome: ten years on. Lancet 342: 341344

    Google Scholar 

  44. Heijboer H, Brandjes DPM, Büller HR, Sturk A, ten Cate JW (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 323: 1512 - 1516

    Article  PubMed  CAS  Google Scholar 

  45. Ferrari E, Imbert A, Chevalier T et al. (1997) The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads-80 case reports. Chest 111: 537 - 543

    Article  PubMed  CAS  Google Scholar 

  46. Stein PD, Goldhaber SZ, Henry JW, Miller AC (1996) Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest 109: 78 - 81

    Article  PubMed  CAS  Google Scholar 

  47. Stein, PD, Goldhaber SZ, Henry JW (1995) Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest 107: 139 - 143

    Article  PubMed  CAS  Google Scholar 

  48. Bounameaux H, de Moerloose P, Perrier A, Miron MJ (1997) D-dimer testing in suspected venous thromboembolism: an update. Q J Med 90: 437 - 442

    Article  CAS  Google Scholar 

  49. Hull RD, Hirsh J, Carter CJ et al. (1983) Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 98:891-899 Overview of Pulmonary Embolism 17

    Google Scholar 

  50. PIOPED Investigators (1990) Value of the ventilation perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 263: 2753 - 2759

    Article  Google Scholar 

  51. Gottschalk A, Sostman HD, Coleman RE et al. (1993) Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations. J Nucl Med 34: 1119-1126

    Google Scholar 

  52. Stein PD, Terrin ML, Gottschalk A, Alavi A, Henry JW (1992) Value of ventilation/perfusion scans versus perfusion scans alone in acute pulmonary embolism. Am J Cardiol 69: 1239 - 1242

    Article  PubMed  CAS  Google Scholar 

  53. Bone RC (1993) The low-probability lung scan. A potentially lethal reading. Arch Intern Med 153: 2621 - 2622

    Article  PubMed  CAS  Google Scholar 

  54. Hull RD, Raskob GE, Pineo GF, Brant RF (1995) The low-probability lung scan. A need for change in nomenclature. Arch Intern Med 155: 1845-1851

    Google Scholar 

  55. Remy-Jardin M, Remy J, Deschildre F et al. (1996) Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 200: 699 - 706

    PubMed  CAS  Google Scholar 

  56. Meaney JFM, Weg JG, Chenevert TL et al. (1997) Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 336: 1422 - 1427

    Article  PubMed  CAS  Google Scholar 

  57. Jardin F, Dubourg O, Bourdarias JP (1997) Echocardiographic pattern of acute cor pulmonale. Chest 111: 209 - 217

    Article  PubMed  CAS  Google Scholar 

  58. McConnell MV, Solomon SD, Rayan ME et al. (1996) Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism ( The "hinge point" sign ). Am J Cardiol 78: 769-473

    Google Scholar 

  59. Stein PD, Athanasoulis C, Alavi A et al. (1992) Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 85: 462 - 468

    Article  PubMed  CAS  Google Scholar 

  60. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S (1993) The weight-based heparin dosing nomogram compared with a "standard care" nomogram: a randomized controlled trial. Ann Intern Med 119: 874 - 881

    PubMed  CAS  Google Scholar 

  61. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA (1997) Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med 157: 2562 - 2568

    Article  PubMed  CAS  Google Scholar 

  62. Toglia M R, Weg JG (1996) Venous thromboembolism during pregnancy. N Engl J Med 335: 108 - 114

    Article  PubMed  CAS  Google Scholar 

  63. Callander N, Rapaport SI (1993) Trousseau's syndrome. West J Med 158: 364 - 371

    PubMed  CAS  Google Scholar 

  64. The COLUMBUS Investigators (1997) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337: 657 - 662

    Article  Google Scholar 

  65. Simonneau G, Sors H, Charbonnier B et al. (1997) A comparison of low-molecularweight-heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 337: 663 - 669

    Article  PubMed  CAS  Google Scholar 

  66. Pacouret G, Alison D, Pottier J-M, Bertrand P, Charbonnier B (1997) Free-floating thrombus and embolis risk in patients with angiographically confirmed proximal deep venous thrombosis. A prospective study. Arch Intern Med 157: 305-308

    Google Scholar 

  67. Decousus H, Leizorovicz A, Parent F et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338: 409 - 415

    Article  PubMed  CAS  Google Scholar 

  68. Harrison L, Johnston M, Massicotte MP, Crowther M, Moffat K, Hirsh J. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 126: 133 - 136

    Google Scholar 

  69. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE (1998) Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 279: 657 - 662

    Article  PubMed  CAS  Google Scholar 

  70. Schulman S, Rhedin A-S, Lindmarker P et al. (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboemholism. N Engl J Med 332: 1661 - 1665

    Article  PubMed  CAS  Google Scholar 

  71. Schulman S, Granqvist S, Holmström et al. (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 336: 393 - 398

    Article  PubMed  CAS  Google Scholar 

  72. Goldhaber SZ, Haire WD, Feldstein ML et al. (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right ventricular function and pulmonary perfusion. Lancet 341: 507 - 511

    Article  PubMed  CAS  Google Scholar 

  73. Konstantinides S, Geibel A, Olschewski M et al. (1997) Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Results of a multicenter registry. Circulation 96: 882-888

    Google Scholar 

  74. Mikkola KM, Patel SR, Parker JA, Grodstein F, Goldhaber SZ (1997) Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J 134: 69 - 72

    Article  PubMed  CAS  Google Scholar 

  75. Greenfield LJ, Proctor MC, Williams DM, Wakefield TW (1993) Long-term experience with transvenous catheter pulmonary embolectomy. J Vasc Surg 18: 450 - 458

    Article  PubMed  CAS  Google Scholar 

  76. Gulba DC, Schmid C, Borst H-G et al. (1994) Medical compared with surgical treatment for massive pulmonary embolism. Lancet 343: 576 - 577

    Article  PubMed  CAS  Google Scholar 

  77. Collins R, Scrimgeour A, Yusuf S, Peto R (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 318: 1162-1173

    Google Scholar 

  78. Weitz JI (1997) Low-molecular-weight heparins. N Engl J Med 337: 688 - 698

    Article  PubMed  CAS  Google Scholar 

  79. Hoek JA, Nurmohamed MT, Hamelynck KJ et al. (1992) Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost 67: 28 - 32

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Japan

About this paper

Cite this paper

Goldhaber, S.Z. (1999). Overview of Pulmonary Embolism. In: Nakano, T., Goldhaber, S.Z. (eds) Pulmonary Embolism. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66893-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-66893-0_1

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-66895-4

  • Online ISBN: 978-4-431-66893-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics